About the Calculation
The Corrected Phenytoin Level calculator is an essential clinical tool for estimating the active concentration of phenytoin in the blood, particularly for patients with low albumin levels (hypoalbuminemia) or severe renal impairment. Phenytoin is highly bound to albumin protein; only the unbound (“free”) portion is pharmacologically active. When albumin is low, the total measured phenytoin level can be misleadingly normal or low, while the free, active level is actually elevated, posing a risk of toxicity.
This calculator uses the validated Winter-Tozer equation to adjust the measured total phenytoin level based on the patient’s serum albumin, providing a more accurate reflection of the drug’s therapeutic effect.
Outputs Explained
After entering the required patient data, the calculator provides the following key outputs:
- Corrected Phenytoin Level: This is the estimated phenytoin concentration as if the patient had a normal albumin level (typically 4.4 g/dL). This value should be used for clinical decision-making.
- Interpretation: The result is categorized to provide immediate clinical context:
- Subtherapeutic: Below the target range (typically <10 mcg/mL), may indicate a need for dose adjustment.
- Therapeutic: Within the target range (typically 10-20 mcg/mL).
- Potentially Toxic: Above the target range (typically >20 mcg/mL), indicating a risk of adverse effects.
- Formula Used: The specific Winter-Tozer formula variation used for the calculation is displayed for transparency, showing the standard or renal-adjusted version.
How to Use This Calculator
To accurately calculate the corrected phenytoin level, follow these steps:
- Enter Measured Total Phenytoin Level: Input the total phenytoin level reported by the laboratory. Ensure the correct units (mcg/mL or mg/L) are selected.
- Enter Serum Albumin: Input the patient’s most recent serum albumin level. Ensure the correct units (g/dL or g/L) are selected. The calculator will automatically convert units as needed for the formula.
- Select Patient Renal Function: Check the box for “Adjust for Severe Renal Impairment” if the patient has end-stage renal disease (ESRD) or a creatinine clearance (CrCl) of less than 25 mL/min. This applies a modified formula to account for altered protein binding in uremia.
The calculator will automatically update the result as you input or change values.
Therapeutic Dosing Overview
Phenytoin has a narrow therapeutic index, meaning the range between effective and toxic doses is small. Careful monitoring is crucial.
- Therapeutic Range (Total Phenytoin): The generally accepted therapeutic range for corrected total phenytoin is 10 to 20 mcg/mL (or mg/L).
- Therapeutic Range (Free Phenytoin): The therapeutic range for free (unbound) phenytoin is 1 to 2 mcg/mL. The corrected total level is an estimate of this active fraction.
- Loading Dose: An initial loading dose may be given to rapidly achieve therapeutic concentrations, especially in status epilepticus.
- Maintenance Dose: Maintenance doses are adjusted based on clinical response, seizure control, and drug levels. Due to phenytoin’s saturable (zero-order) metabolism, small dose increases can lead to disproportionately large increases in serum levels.
Switching Formulations
When switching between phenytoin formulations, careful monitoring is required.
- IV to Oral: When transitioning from IV phenytoin to oral capsules, the same total daily dose is typically used. However, absorption rates differ, so levels should be re-checked after reaching a new steady state (usually 5-10 days).
- Fosphenytoin: Fosphenytoin is a water-soluble prodrug of phenytoin used for IV/IM administration. It is dosed in phenytoin sodium equivalents (PE). Dosing conversions are 1:1 (e.g., 100 mg PE of fosphenytoin delivers 100 mg of phenytoin sodium). This calculator can be used for levels drawn after fosphenytoin has fully converted to phenytoin.
Missed Dose Protocol
If a patient misses a dose of phenytoin, they should be advised to take it as soon as they remember. However, if it is almost time for the next dose, they should skip the missed dose and resume their regular dosing schedule. Patients should never double their dose to make up for a missed one. Consistently missing doses can lead to subtherapeutic levels and loss of seizure control. Advise patients to contact their healthcare provider for specific instructions.
Safety Alerts
Always interpret calculator results in the context of the patient’s clinical condition.
- Toxicity: Corrected levels above 20 mcg/mL increase the risk of toxicity. Signs include nystagmus (involuntary eye movements), ataxia (unsteady gait), slurred speech, lethargy, and confusion. Levels >30 mcg/mL can lead to severe toxicity, including coma.
- Drug Interactions: Numerous drugs can affect phenytoin levels by altering its metabolism or displacing it from albumin (e.g., valproic acid, warfarin, salicylates). The Winter-Tozer equation does not account for displacement by other drugs.
- Low Albumin Reliability: The formula’s accuracy may decrease at very low albumin levels (e.g., < 2.0 g/dL). In such cases, or if clinical suspicion of toxicity is high despite a "normal" corrected level, ordering a direct free phenytoin level is recommended.
Frequently Asked Questions
Why is correcting phenytoin for albumin important?
Phenytoin is over 90% bound to albumin in the blood. Only the unbound “free” fraction can enter the brain to stop seizures. In patients with low albumin, a standard total phenytoin level may appear normal, but the free fraction can be dangerously high. Correcting for albumin gives a more accurate picture of the clinically active drug level.
What is the Winter-Tozer equation?
It is a mathematical formula used to estimate the corrected phenytoin concentration. The standard formula is: Corrected Level = Measured Level / ((0.2 * Albumin) + 0.1). A modified version with a different multiplier for albumin (0.1 instead of 0.2) is used for patients with severe renal impairment.
When should I order a free phenytoin level instead?
Measuring a direct free phenytoin level is the gold standard and should be considered when: the patient has very low albumin (<2.0 g/dL), there is a strong clinical suspicion of toxicity despite a calculated therapeutic level, or the patient is taking other drugs that significantly displace phenytoin from albumin (like valproic acid).
How does severe renal failure affect phenytoin binding?
In severe renal failure or end-stage renal disease (ESRD), uremic toxins build up in the blood. These toxins can compete with phenytoin for binding sites on albumin, leading to a higher free fraction even at normal albumin levels. The “renal impairment” formula in the calculator adjusts for this effect.
What albumin level is considered “low”?
While the normal range varies slightly by lab, an albumin level below 3.5 g/dL is generally considered low (hypoalbuminemia). The need for correction becomes more critical as the albumin level drops further.
Can I use this calculator for fosphenytoin?
Yes, but only after the fosphenytoin has been fully converted to phenytoin in the body, which typically takes about 15-30 minutes after IV infusion. The blood sample should be for a “phenytoin” level, not fosphenytoin.
What are the most common early signs of phenytoin toxicity?
The earliest and most common sign of phenytoin toxicity is horizontal nystagmus (jerky, involuntary movement of the eyes when looking to the side). As levels rise, ataxia (difficulty with balance and coordination), slurred speech, and drowsiness can occur.
Is the corrected phenytoin level accurate in all patients?
It is a clinically validated estimate and is accurate for most patients. However, its reliability can decrease in complex cases involving multiple protein-binding drugs, extremely low albumin, or significant metabolic changes. Always use it as one part of a comprehensive clinical assessment.
References
- U.S. Food and Drug Administration. DILANTIN® (extended phenytoin sodium capsules) Prescribing Information. Pfizer Inc. Updated May 2024. Available at: FDA.gov.
- Patel J, M Das J, et al. Phenytoin Toxicity. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available at: NCBI StatPearls.
- Winter ME, Tozer TN. The phenytoin chapter. In: Winter ME. Basic clinical pharmacokinetics. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010:359-93.
- Anderson GD, Pakarinen ED, et al. Revisiting the Winter-Tozer equation for correcting phenytoin concentrations in trauma and critically ill patients. Am J Health Syst Pharm. 2011 Mar 1;68(5):409-13. doi: 10.2146/ajhp100342. Available at: PubMed.
